Avanos Medical Inc logo

AVNS - Avanos Medical Inc Share Price

$47.65 -0.1  -0.3%

Last Trade - 26/01/21

Sector
Healthcare
Size
Mid Cap
Market Cap £1.67bn
Enterprise Value £1.72bn
Revenue £526.3m
Position in Universe 2004th / 6627
Bullish
Bearish
Unlock AVNS Revenue
Momentum
Relative Strength (%)
1m -0.58%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -4.46%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
1,672 509 566.2 611.6 652.3 697.6 710.8 737.9 -16.0%
-62.7 +15.9 +257.8 +57.2
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2020, AvanosMedical Inc revenues increased 4% to $529.8M. Net incometotaled $20M vs. loss of $39.8M. Revenues reflect ChronicCare segment increase of 18% to $355.2M, Europe, MiddleEast and Africa segment increase of 23% to $81.8M, AsiaPacific and Latin America segment increase of 12% to$51.9M. Net Income reflects Other expense, net decrease of50% to $10M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AVNS Revenue Unlock AVNS Revenue

Net Income

AVNS Net Income Unlock AVNS Revenue

Normalised EPS

AVNS Normalised EPS Unlock AVNS Revenue

PE Ratio Range

AVNS PE Ratio Range Unlock AVNS Revenue

Dividend Yield Range

AVNS Dividend Yield Range Unlock AVNS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AVNS EPS Forecasts Unlock AVNS Revenue
Profile Summary

Avanos Medical, Inc., formerly Halyard Health, Inc., is a medical technology company. The Company provides a portfolio of product offerings focused on surgical and interventional pain management, respiratory and digestive health. Its products include post-operative pain management solutions, minimally invasive interventional or chronic pain therapies, closed airway suction systems and enteral feeding tubes. The company’s products are sold under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, QUIKBLOC, HOMEPUMP, CORTRAK and other brand names.

Directors
Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated February 25, 2014
Public Since October 21, 2014
No. of Shareholders: 12,576
No. of Employees: 4,700
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange New York Stock Exchange
Shares in Issue 47,833,115
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AVNS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AVNS
Upcoming Events for AVNS
Tuesday 23rd February, 2021 Estimate
Q4 2020 Avanos Medical Inc Earnings Release
Tuesday 4th May, 2021 Estimate
Q1 2021 Avanos Medical Inc Earnings Release
Frequently Asked Questions for Avanos Medical Inc
What is the Avanos Medical Inc share price?

As of 26/01/21, shares in Avanos Medical Inc are trading at $47.65, giving the company a market capitalisation of £1.67bn. This share price information is delayed by 15 minutes.

How has the Avanos Medical Inc share price performed this year?

Shares in Avanos Medical Inc are currently trading at $47.65 and the price has moved by 59.55% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Avanos Medical Inc price has moved by 34.72% over the past year.

What are the analyst and broker recommendations for Avanos Medical Inc?

Of the analysts with advisory recommendations for Avanos Medical Inc, there are there are currently 1 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Avanos Medical Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Avanos Medical Inc next release its financial results?

Avanos Medical Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Avanos Medical Inc dividend yield?

Avanos Medical Inc does not currently pay a dividend.

Does Avanos Medical Inc pay a dividend?

Avanos Medical Inc does not currently pay a dividend.

When does Avanos Medical Inc next pay dividends?

Avanos Medical Inc does not currently pay a dividend.

How do I buy Avanos Medical Inc shares?

To buy shares in Avanos Medical Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Avanos Medical Inc?

Shares in Avanos Medical Inc are currently trading at $47.65, giving the company a market capitalisation of £1.67bn.

Where are Avanos Medical Inc shares listed? Where are Avanos Medical Inc shares listed?

Here are the trading details for Avanos Medical Inc:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: AVNS
What kind of share is Avanos Medical Inc?

Based on an overall assessment of its quality, value and momentum, Avanos Medical Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Avanos Medical Inc share price forecast 2021?

Shares in Avanos Medical Inc are currently priced at $47.65. At that level they are trading at 8.73% premium to the analyst consensus target price of 0.00.

Analysts covering Avanos Medical Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.698 for the next financial year.

How can I tell whether the Avanos Medical Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Avanos Medical Inc. Over the past six months, the relative strength of its shares against the market has been 23.49%. At the current price of $47.65, shares in Avanos Medical Inc are trading at 34.63% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Avanos Medical Inc PE Ratio?

The Avanos Medical Inc PE ratio based on its reported earnings over the past 12 months is 73.79. The shares are currently trading at $47.65.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Avanos Medical Inc?

Avanos Medical Inc's management team is headed by:

John Byrnes - IND
Maria Sainz - IND
Heidi Kunz - IND
Gary Blackford - CHM
Patrick O'Leary - IND
William Hawkins - IND
Joseph Woody - CEO
Arjun Sarker - SVP
David Ball - SVP
Michael Greiner - CFO
William Haydon - SVP
Michelle Scharfenberg - SVP
S. Ross Mansbach - SVP
Who are the major shareholders of Avanos Medical Inc?

Here are the top five shareholders of Avanos Medical Inc based on the size of their shareholding:

BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 9.7% (4.64m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 8.83% (4.23m shares)
Wellington Management Company, LLP Investment Advisor/Hedge Fund
Percentage owned: 8.33% (3.99m shares)
T. Rowe Price Associates, Inc. Investment Advisor
Percentage owned: 7.43% (3.55m shares)
Champlain Investment Partners, LLC Investment Advisor
Percentage owned: 7.07% (3.38m shares)
Similar to AVNS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.